‘Large, innovative’ CBD sector needs balanced rules, says FDA advisor
Federal CBD policy should advance research that can inform consumers about risk while at the same time giving stakeholders regulatory certainty, a senior advisor at the U.S. Food and Drug […]
‘Large, innovative’ CBD sector needs balanced rules, says FDA advisor Read More »